Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Okamoto

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
American Journal of Hematology|January 26, 2016
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman diseaseNoriko Iwaki, David C Fajgenbaum, Christopher S Nabel, et al.
Leukemia & Lymphoma|July 1, 2014
Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphomaSatoko Morishima, Shigeo Nakamura, Kazuhito Yamamoto, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Eclinicalmedicine|February 19, 2025
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, et al.
Journal of Hepatology|March 21, 2020
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphomaShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.
The Lancet. Oncology|March 15, 2020
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2015
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational StudyShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.
Hematological Oncology|February 12, 2025
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational StudyYuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
American Journal of Hematology|January 26, 2016
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman diseaseNoriko Iwaki, David C Fajgenbaum, Christopher S Nabel, et al.
Leukemia & Lymphoma|July 1, 2014
Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphomaSatoko Morishima, Shigeo Nakamura, Kazuhito Yamamoto, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Eclinicalmedicine|February 19, 2025
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, et al.
Journal of Hepatology|March 21, 2020
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphomaShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.
The Lancet. Oncology|March 15, 2020
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2015
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational StudyShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.
Hematological Oncology|February 12, 2025
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational StudyYuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Pageof 7